Kevin Noonan, Sep 30, 2013
In June, the Supreme Court ruled 5-3 in favor of the Federal Trade Commission in FTC v. Actavis, Inc. Writing for the majority (that included Justices Kennedy, Ginsburg, Sotomayor, and Kagan), Justice Breyer’s opinion reversed the decision of the Eleventh Circuit Court of Appeals dismissing the FTC’s complaint that a “reverse payment” settlement agreement between an innovator drug maker and generic challengers in ANDA litigation was anticompetit
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.131.13.194
Please verify email or join us to access premium content!